002880.SZ
Shenzhen Weiguang Biological Products Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 20.50
−2.94%Year over year
Reported trailing growth
- Revenue
- +5.1%
- EBITDA
- —
- EBIT
- -8.3%
- EPS
- -6.8%
- Free cash flow
- -39.3%
- Operating cash flow
- -41.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +23.8%
- EBITDA
- +29.4%
- EBIT
- +27.1%
- Net income
- +28.0%
- EPS
- +28.0%
- Free cash flow
- +16.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026